Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
Mon, June 26, 2023
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
[ Mon, Jun 26th 2023
] - WOPRAI
Ed Arce Reiterated (CDTX) at Strong Buy and Held Target at $120 on, Jun 26th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $120 on, Jun 26th, 2023.
Ed has made no other calls on CDTX in the last 4 months.
There are 2 other peers that have a rating on CDTX. Out of the 2 peers that are also analyzing CDTX, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $60 on, Friday, May 12th, 2023
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $100 on, Wednesday, March 8th, 2023
